|
IT1199374B
(it)
*
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US7048906B2
(en)
*
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
KR100407851B1
(ko)
*
|
1997-02-28 |
2004-04-29 |
가네가후치 가가쿠고교 가부시키가이샤 |
헬리코박터의감염에기인하는질환치료제
|
|
EP1453837A4
(en)
*
|
2001-11-21 |
2007-11-07 |
Activbiotics Inc |
TARGETED THERAPEUTIC AGENTS AND USES THEREOF
|
|
WO2003051299A2
(en)
*
|
2001-12-13 |
2003-06-26 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
WO2004041240A1
(en)
*
|
2002-11-05 |
2004-05-21 |
Piero Chiarelli |
Controlled and continued delivery of rifaximin and/or other substances
|
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
PL1698630T3
(pl)
|
2005-03-03 |
2014-12-31 |
Alfasigma Spa |
Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
WO2007096703A2
(en)
|
2005-08-11 |
2007-08-30 |
Targanta Therapeutics Inc. |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
BRPI0708561A2
(pt)
|
2006-03-09 |
2011-06-07 |
Salix Pharmaceuticals Inc |
preparação farmacêutica, e métodos de tratamento de um indivìduo que sofre de um distúrbio anal, e de avaliação da eficácia de um tratamento de distúrbio anal em um indivìduo, monitoramento do progresso de um indivìduo sendo tratado para um distúrbio anal, ou um método de seleção de um indivìduo para o tratamento de distúrbio anal
|
|
MX2009001342A
(es)
|
2006-08-02 |
2009-08-31 |
Salix Pharmaceuticals Inc |
Composiciones y metodos para el tratamiento de proctosigmoiditis por radiacion.
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
JP2010504314A
(ja)
*
|
2006-09-22 |
2010-02-12 |
シプラ・リミテッド |
リファキシミン
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
US8383151B2
(en)
|
2007-07-06 |
2013-02-26 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
|
ES2389358T5
(es)
|
2007-07-06 |
2016-01-19 |
Lupin Ltd. |
Composiciones farmacéuticas de rifaximina
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
MX2010009389A
(es)
|
2008-02-25 |
2010-11-22 |
Salix Pharmaceuticals Ltd |
Formas de rifaximina y sus usos.
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
NZ587098A
(en)
|
2008-02-26 |
2012-09-28 |
Salix Pharmaceuticals Ltd |
Use of a rifamycin class antibiotic for treating diarrhea-associated Irritable Bowel Syndrome and hepatic encephalopathy
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
DK2294012T3
(da)
|
2008-05-07 |
2014-10-06 |
Salix Pharmaceuticals Ltd |
Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom
|
|
US8524691B2
(en)
|
2008-08-13 |
2013-09-03 |
The Medicines Company |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
BRPI0918997A2
(pt)
|
2008-09-26 |
2015-12-01 |
Aska Pharm Co Ltd |
agente para evitar e/ou tratar um disturbio gastrointestinal funcional.
|
|
US12285414B2
(en)
|
2008-10-02 |
2025-04-29 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
EP2350096B1
(en)
|
2008-10-02 |
2019-12-11 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
WO2010067072A1
(en)
|
2008-12-10 |
2010-06-17 |
Cipla Limited |
Rifaximin complexes
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
KR20120025578A
(ko)
|
2009-06-02 |
2012-03-15 |
샐릭스 파마슈티컬스 리미티드 |
간성 뇌병증의 치료방법
|
|
RU2582940C2
(ru)
|
2009-09-13 |
2016-04-27 |
Саликс Фармасьютикалз, Лтд. |
Способы лечения синдрома раздраженного кишечника (срк)
|
|
SG10201501054TA
(en)
|
2009-10-27 |
2015-04-29 |
Lupin Ltd |
Solid dispersion of rifaximin
|
|
CN102724960A
(zh)
|
2009-11-23 |
2012-10-10 |
希普拉有限公司 |
局部泡沫组合物
|
|
US8952159B2
(en)
|
2009-12-28 |
2015-02-10 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
AU2011218129A1
(en)
|
2010-02-18 |
2012-08-23 |
Board Of Regents Of The University Of Texas System |
Methods for treating infection
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
WO2011110930A2
(en)
|
2010-03-10 |
2011-09-15 |
Lupin Limited |
Rifaximin ready-to-use suspension
|
|
CA2804635C
(en)
|
2010-07-12 |
2019-09-10 |
Salix Pharmaceuticals, Ltd. |
Formulations of rifaximin and uses thereof
|
|
WO2012035544A2
(en)
|
2010-09-13 |
2012-03-22 |
Sequent Scientific Ltd. |
A novel polymorphic form of rifaximin and process for its preparation
|
|
MX350448B
(es)
|
2011-02-11 |
2017-09-07 |
Salix Pharmaceuticals Ltd |
Formas de rifaximina y usos de las mismas.
|
|
WO2012150561A1
(en)
|
2011-05-02 |
2012-11-08 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
|
US20130184302A1
(en)
|
2011-11-02 |
2013-07-18 |
Enoch Bortey |
Methods for treating irritable bowel syndrome (ibs) and infections
|
|
CA2861104A1
(en)
|
2012-01-25 |
2013-08-01 |
Salix Pharmaceuticals, Ltd. |
Rifaximin derivative and uses thereof
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
WO2014091432A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of rifaximin
|
|
CA2897758A1
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
|
EP2971062A2
(en)
|
2013-03-15 |
2016-01-20 |
ALFA WASSERMANN S.p.A. |
Method for diagnosing vaginal infections
|
|
CA2908525C
(en)
|
2013-04-12 |
2021-04-06 |
Alfa Wassermann S.P.A. |
Nsaid administration and related compositions, methods and systems
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
ES2621557T3
(es)
|
2014-03-31 |
2017-07-04 |
Euticals S.P.A. |
Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
|
|
WO2015159275A2
(en)
*
|
2014-04-19 |
2015-10-22 |
Granules India Limited |
An improved process for the preparation of rifamycin derivatives
|
|
WO2015171493A1
(en)
|
2014-05-04 |
2015-11-12 |
Salix Pharmaceuticals, Inc. |
Ibs microbiota and uses thereof
|
|
CA2940601C
(en)
|
2014-05-12 |
2021-08-24 |
Alfa Wassermann S.P.A. |
New solvated crystal form of rifaximin, production, compositions and uses thereof
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
PT3518924T
(pt)
|
2016-09-30 |
2022-10-27 |
Salix Pharmaceuticals Inc |
Formas de dispersão sólidas de rifaximina
|
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
|
HUE054832T2
(hu)
*
|
2017-06-26 |
2021-10-28 |
Biofer Spa |
Pirido-imidazo rifamicinszármazékok baktériumellenes szerként
|